Associations of filaggrin gene loss-of-function variants with urinary phthalate metabolites and testicular function in young Danish men

Environmental Health Perspectives

Volumn 122, Issue 4, 2014, Pages 345-350

  Joensen, Ulla Nordström ^a   Jørgensen, Niels ^a   Meldgaard, Michael ^b   Frederiksen, Hanne ^a   Andersson, Anna Maria ^a   Menné, Torkil ^b   Johansen, Jeanne Duus ^b   Carlsen, Berit Christina ^b   Stender, Steen ^b   Szecsi, Pal Bela ^b   Skakkebæk, Niels Erik ^a   Rajpert De Meyts, Ewa ^a   Thyssen, Jacob P ^b  

^a Rigshospitalet   (Denmark)

^b GENTOFTE UNIVERSITY HOSPITAL   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

FILAGGRIN; MONO 3 CARBOXYPROPYL PHTHALATE; MONO ISONONYL PHTHALATE; MONO N BUTYL PHTHALATE; MONO N OCTYL PHTHALATE; MONOBENZYL PHTHALATE; PHTHALIC ACID; PHTHALIC ACID ESTER; PHTHALIC ACID ISOBUTYL ESTER; UNCLASSIFIED DRUG; INTERMEDIATE FILAMENT PROTEIN; PHTHALIC ACID DERIVATIVE;

ADULT; ARTICLE; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; GENETIC VARIABILITY; GENOTYPE; HUMAN; LOSS OF FUNCTION MUTATION; MALE; METABOLITE; OSMOLALITY; PRIORITY JOURNAL; QUESTIONNAIRE; SEMEN ANALYSIS; TESTIS FUNCTION; YOUNG ADULT; ADOLESCENT; GENETIC PREDISPOSITION; GENETICS; METABOLISM; PHYSIOLOGY; TESTIS; URINE;

ADOLESCENT; ADULT; CROSS-SECTIONAL STUDIES; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; INTERMEDIATE FILAMENT PROTEINS; MALE; PHTHALIC ACIDS; TESTIS; YOUNG ADULT;

EID: 84897465613     PISSN: 00916765     EISSN: 15529924     Source Type: Journal    
DOI: 10.1289/ehp.1306720     Document Type: Article

References (33)

1. Blomberg JM, Bjerrum PJ, Jessen TE, Nielsen JE, Joensen UN, Olesen IA, et al. 2011. Vitamin D is positively associated with sperm motility and increases intracellular calcium in human spermatozoa. Hum Reprod 26:1307-1317.
2. Boberg J, Christiansen S, Axelstad M, Kledal TS, Vinggaard AM, Dalgaard M, et al. 2011. Reproductive and behavioral effects of diisononyl phthalate (DINP) in perinatally exposed rats. Reprod Toxicol 31:200-209.
3. Brown SJ, Asai Y, Cordell HJ, Campbell LE, Zhao Y, Liao H, et al. 2011. Loss-of-function variants in the filaggrin gene are a significant risk factor for peanut allergy. J Allergy Clin Immunol 127:661-667.
4. Desdoits-Lethimonier C, Albert O, Le BB, Perdu E, Zalko D, Courant F, et al. 2012. Human testis steroidogenesis is inhibited by phthalates. Hum Reprod 27:1451-1459.
5. European Chemical Agency. 2010. Evaluation of New Scientific Evidence Concerning the Restrictions Contained in Annex XVII to Regulation (EC) No. 1907/2006 (REACH): Review of New Available Information for Di-'isononyl' Phthalate (DINP). Available: http://echa.europa.eu/documents/10162/13641/dinp_echa_review_report_2010_6_en.pdf [accessed 1 February 2013].
6. Fallon PG, Sasaki T, Sandilands A, Campbell LE, Saunders SP, Mangan NE, et al. 2009. A homozygous frameshift mutation in the mouse Flg gene facilitates enhanced percutaneous allergen priming. Nat Genet 41:602-608.
7. Frederiksen H, Jørgensen N, Andersson AM. 2010. Correlations between phthalate metabolites in urine, serum, and seminal plasma from young Danish men determined by isotope dilution liquid chromatography tandem mass spectrometry. J Anal Toxicol 34:400-410.
8. Gray LE Jr, Ostby J, Furr J, Price M, Veeramachaneni DN, Parks L. 2000. Perinatal exposure to the phthalates DEHP, BBP, and DINP, but not DEP, DMP, or DOTP, alters sexual differentiation of the male rat. Toxicol Sci 58:350-365.
9. Gruber R, Elias PM, Crumrine D, Lin TK, Brandner JM, Hachem JP, et al. 2011. Filaggrin genotype in ichthyosis vulgaris predicts abnormalities in epidermal structure and function. Am J Pathol 178:2252-2263.
10. Hauser R, Meeker JD, Park S, Silva MJ, Calafat AM. 2004. Temporal variability of urinary phthalate metabolite levels in men of reproductive age. Environ Health Perspect 112:1734-1740; doi:10.1289/ehp.7212.
11. Irvine AD, McLean WH, Leung DY. 2011. Filaggrin mutations associated with skin and allergic diseases. N Engl J Med 365:1315-1327.
12. Janjua NR, Frederiksen H, Skakkebæk NE, Wulf HC, Andersson AM. 2008. Urinary excretion of phthalates and paraben after repeated whole-body topical application in humans. Int J Androl 31:118-130.
13. Joensen UN, Frederiksen H, Jensen MB, Lauritsen MP, Olesen IA, Lassen TH, et al. 2012. Phthalate excretion pattern and testicular function: a study of 881 healthy Danish men. Environ Health Perspect 120:1397-1403; doi:10.1289/ehp.1205113.
14. Jørgensen N, Carlsen E, Nermoen I, Punab M, Suominen J, Andersen AG, et al. 2002. East-west gradient in semen quality in the Nordic-Baltic area: a study of men from the general population in Denmark, Norway, Estonia and Finland. Hum Reprod 17:2199-2208.
15. Jørgensen N, Joensen UN, Jensen TK, Jensen MB, Almstrup K, Olesen IA, et al. 2012. Human semen quality in the new millennium: a prospective cross-sectional population-based study of 4867 men. BMJ Open; doi:10.1136/bmjopen-2012-000990 [Online 2 July 2012].
16. Kimber I, Dearman RJ. 2010. An assessment of the ability of phthalates to influence immune and allergic responses. Toxicology 271:73-82.
17. Koch HM, Bolt HM, Preuss R, Angerer J. 2005. New metabolites of di(2-ethylhexyl)phthalate (DEHP) in human urine and serum after single oral doses of deuterium-labelled DEHP. Arch Toxicol 79:367-376.
18. McFadden JP, White JM, Basketter DA, Kimber I. 2009. Does hapten exposure predispose to atopic disease? The hapten-atopy hypothesis. Trends Immunol 30:67-74.
19. Meeker JD, Calafat AM, Hauser R. 2009. Urinary metabolites of di(2-ethylhexyl) phthalate are associated with decreased steroid hormone levels in adult men. J Androl 30:287-297.
20. Meldgaard M, Szecsi PB, Carlsen BC, Thyssen JP, Johansen JD, Menné T, et al. 2012. A novel multiplex analysis of filaggrin polymorphisms: a universally applicable method for genotyping. Clin Chim Acta 413:1488-1492.
21. Mendiola J, Jørgensen N, Andersson AM, Calafat AM, Silva MJ, Redmon JB, et al. 2011. Associations between urinary metabolites of di(2-ethylhexyl) phthalate and reproductive hormones in fertile men. Int J Androl 34:369-378.
22. Menkveld R, Stander FS, Kotze TJ, Kruger TF, van Zyl JA. 1990. The evaluation of morphological characteristics of human spermatozoa according to stricter criteria. Hum Reprod 5:586-592.
23. Online Encyclopedia for Genetic Epidemiology. 2008. Hardy-Weinberg Equilibrium Calculator Including Analysis for Ascertainment Bias. Available: http://www.oege.org/software/hwe-mr-calc.shtml [accessed 5 February 2014].
24. Palmer CN, Irvine AD, Terron-Kwiatkowski A, Zhao Y, Liao H, Lee SP, et al. 2006. Common loss-of-function variants of the epidermal barrier protein filaggrin are a major predisposing factor for atopic dermatitis. Nat Genet 38:441-446.
25. Scharschmidt TC, Man MQ, Hatano Y, Crumrine D, Gunathilake R, Sundberg JP, et al. 2009. Filaggrin deficiency confers a paracellular barrier abnormality that reduces inflammatory thresholds to irritants and haptens. J Allergy Clin Immunol 124:496-506.
26. Sergeant A, Campbell LE, Hull PR, Porter M, Palmer CN, Smith FJ, et al. 2009. Heterozygous null alleles in filaggrin contribute to clinical dry skin in young adults and the elderly [Letter]. J Invest Dermatol 129:1042-1045.
27. Smith FJ, Irvine AD, Terron-Kwiatkowski A, Sandilands A, Campbell LE, Zhao Y, et al. 2006. Loss-of-function mutations in the gene encoding filaggrin cause ichthyosis vulgaris. Nat Genet 38:337-342.
28. Thyssen JP, Johansen JD, Linneberg A, Menne T, Nielsen NH, Meldgaard M, et al. 2010. The association between null mutations in the filaggrin gene and contact sensitization to nickel and other chemicals in the general population. Br J Dermatol 162:1278-1285.
29. Thyssen JP, Linneberg A, Johansen JD, Carlsen BC, Zachariae C, Meldgaard M, et al. 2012a. Atopic diseases by filaggrin mutations and birth year. Allergy 67:705-708.
30. Thyssen JP, Thuesen B, Huth C, Standl M, Carson CG, Heinrich J, et al. 2012b. Skin barrier abnormality caused by filaggrin (FLG) mutations is associated with increased serum 25-hydroxyvitamin D concentrations [Letter]. J Allergy Clin Immunol 130:1204-1207.
31. Vermeulen A, Verdonck L, Kaufman JM. 1999. A critical evaluation of simple methods for the estimation of free testosterone in serum. J Clin Endocrinol Metab 84:3666-3672.
32. Wittassek M, Koch HM, Angerer J, Bruning T. 2011. Assessing exposure to phthalates-the human biomonitoring approach. Mol Nutr Food Res 55:7-31.
33. WHO (World Health Organization). 2010. WHO Laboratory Manual for the Examination and Processing of Human Semen. 5th ed. Available: http://whqlibdoc.who.int/publications/2010/9789241547789_eng.pdf [accessed 1 February 2013].